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Abstract: Background: Walking pace is a well-known indicator of physical capability, but it is also a
strong predictor of type 2 diabetes (T2D). However, there is a lack of evidence on the association between
walking pace and T2D, specifically, within developing countries such as Chile. Aim: To investigate the
association between self-reported walking pace and T2D in the Chilean adult population. Methods:
5520 Chilean participants (aged 15 to 90 years, 52.1% women) from the Chilean National Health Survey
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2016–2017 were included in this cross-sectional study. Both walking pace (slow, average, and brisk) and
diabetes data were collected through self-reported methods. Fasting blood glucose (reported in mg/dl)
and glycosylated haemoglobin A (HbA1c) scores were determined via blood exams. Results: In the
unadjusted model, and compared to people who reported a slow walking pace, those with average
and brisk walking pace had lower blood glucose levels (β = −7.74 mg/dL (95% CI: −11.08 to −4.40) and
β = −11.05 mg/dL (95% CI: −14.36 to −7.75), respectively) and lower HbA1c (β = −0.34% (95% CI: −0.57
to −0.11) and β= −0.72% (95% CI: −0.94 to −0.49)), respectively. After adjusting for sociodemographic,
Body Mass Index and lifestyle factors, the association between glycaemia and HbA1c remained only for
brisk walkers. Both the average and brisk walker categories had lower odds of T2D (OR: 0.59 (95% CI:
0.41 to 0.84) and (OR 0.48 (95% CI: 0.30 to 0.79), respectively). Conclusion: Brisk walkers were associated
with lower blood glucose and HbA1c levels. Moreover, average to brisk walking pace also showed a
lower risk for T2D.
Keywords: walking pace; diabetes mellitus; glucose; glycosylated haemoglobin A; health surveys;
Chile (MeSH)
1. Introduction
Type 2 Diabetes (T2D) is a rising public health problem worldwide, specifically within the Chilean
adult population. On a global scale, T2D affects 1 in 11 adults between the ages of 20 and 79 years old
(currently 425 million adults worldwide live with diabetes) [1]. According to the International Diabetes
Federation (IDF) the prevalence of T2D in Central and South America will increase to affect 62% of the
population (from 26 to 42 million people) between 2017 and 2045 [2]. The Chilean National Health
Survey 2016–2017 (CNHS 2016–2017) reported that, currently, 12.6% of the population has T2D [3].
This statistic is extremely concerning given that the World Health Organization (WHO) has identified
that the direct health costs associated with T2D have reached a staggering US $827 billion per annum.
Moreover, the indirect health costs are reported to be US $1.7 billion [4].
Although physical capability markers are generally used to predict morbidity and mortality in
older adults [5,6], there is increasing evidence that walking pace could also be a strong predictor of
health outcomes among middle-aged adults [7–9]. In a recent UK Biobank study, >500,000 participants
were recruited between the ages of 40 and 70. This study reported that individuals with a brisk
walking pace had a lower risk of developing cardiovascular (38%), respiratory diseases (42%), chronic
pulmonary obstruction disease (74%) and premature mortality (21%) compared to slow walkers [7].
Moreover, walking pace is also a strong predictor of health in older adults. Recent international
reports suggesting that walking pace is an important risk factor associated with fatigue, sarcopenia,
osteoarthritis, disability, hospitalisation, falls, premature mortality, cancer, depression, cognitive
impairment, high blood pressure, obesity, and T2D in older adults [10–15].
However, most of the current evidence about walking pace as a predictor of health outcomes
has been generated within developed countries and does not extend to developing countries, such as
Chile. In fact, only two studies have evaluated the association of walking speed with health outcomes
in South America (one of them in Chile) [16,17]. Over the past two decades, Chile has undergone
important health and epidemiological transitions. Currently, Chile is ranked third in Latin America for
its prevalence rates of T2D, hypertension and obesity. Additionally, 24% of the population is reported
to be physically inactive [18], increasing this prevalence with age [19]. Therefore, different strategies
are needed to increase physical activity levels and maximise its various health benefits [20]. As walking
pace could be a free, cheap, and feasible alternative to increase those health benefits, especially for
those with T2D [20]. This study aimed to investigate the association of walking pace with T2D and
diabetes biomarkers in a national representative sample of Chilean adults.
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2. Materials and Methods
2.1. Study Design
This cross-sectional population study is composed of 6233 participants recruited from the Chilean
National Health Survey conducted between 2016–2017 (CNHS 2016–2017). The CNHS 2016–2017 was
conducted within Chilean households with participants over 15-years-old. Out of 6233 who took part
in the CNHS only 5520 participants had blood glucose and glycosylated haemoglobin tests.
The present study was conducted according to the guidelines laid down in the Declaration of
Helsinki, and the CNHS 2016–2017 has been reviewed by the Ministry of Health and ethically approved
by the School of Medicine of the Pontifical Catholic University of Chile (16-019). All participants of the
CNHS 2016–2017 provided written consent prior to participation [3].
2.2. Walking Pace
Walking pace was determined through the following questions “How would you describe your
usual walking pace?” from which participants were asked to select one of the following three walking
pace options slow, average, or brisk pace. The time allocated for physical activity (PA) related to
transportation (walking, cycling) and moderate or vigorous intensity activities during leisure and/or
work, were determined according to the GPAQ analysis guide (Global Physical Activity Questionnaire
v2) [21,22]. To estimate total PA levels, the variables were expressed in METs (Metabolic equivalent of
Task). An energy expenditure <600 MET/minutes/week, or its equivalent of 150 min of moderate to
vigorous-intensity PA or 75 min of vigorous-intensity PA per week or its combination, was considered
as a cut-off point for physical inactivity, according to the WHO recommendations and specifications of
the GPAQ analysis guide [21,22]. Sedentary levels were determined by the self-report of time allocated
to activities that involve sitting or reclining during free time or work (time sitting at the computer,
watching television, travelling by bus, train, car, etc.) [21,22].
2.3. Diabetes Mellitus
The diagnosis of T2D was determined by the presence of any of the following three criteria: (a)
Self-reported medical diagnosis of T2D, (b) Being under medical prescription for T2D, (c) Having
fasting baseline glycaemic values >126 mg/dL [3].
2.4. Sociodemographics, Health, and Lifestyle
The sociodemographic variables age, sex (male or female), age group (15–37, 37–56, or >56 years),
educational level (primary < 8, secondary 8 to 12 or higher education > 12 years), area of residence
(rural or urban) and lifestyle variables: smoking habits, alcohol use (AUDIT scale), salt, fruit and
vegetable intake, sleep hours and self-perception of health and personal wellbeing were obtained
through the application of validated questionnaires of the CHNS 2016–2017 [3].
Weight was measured using a digital scale (Tanita HD-313®, Tokyo, Japan) and Height with a
height rod in participant homes. Participants did not wear shoes and were dressed in light clothing for
both measurements. These were both carried out through standardised methods and by trained nurses
or midwives, as described elsewhere3. Nutritional status and body fat were determined according to
Body Mass Index (BMI) based on the cut-off points of the WHO: underweight: <18.5 kg/m2; normal
weight: 18.5–24.9 kg/m2; overweight: 25.0–29.9 kg/m2 and obesity: ≥30.0 kg/m2. Central obesity was
defined as waist circumference (WC) ≥88 cm for women and ≥102 cm for men [23].
Blood glucose levels were determined according to HbA1c (glycosylated haemoglobin A) and
glycaemia, through a blood sample, which was drawn after 11 h of fasting by trained nurses. The results
were classified according to the parameters proposed by the American Diabetes Association (ADA):
Normal HbA1c: 5.7%; HbA1c 5.7–6.4%: pre-diabetes; HbA1c greater than 6.5%: T2D [24].
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2.5. Statistical Analyses
All analyses were performed with STATA 15 software (Statacorp; College Station, TX, USA).
The analyses were performed by weighting the survey to the total national population, as suggested in
the CNHS 2016–2017. Significant differences were accepted with a p-value < 0.05.
The characterisation data of the population studied were presented as weighted means for
continuous variables and as a weighted prevalence for categorical variables with their corresponding
95% confidence intervals (95% CI).
The association of walking pace with fasting glucose and HbA1c were investigated using linear
regression analyses. Data were presented as β-coefficient and its 95% CI. The association between
walking pace and T2D was investigated with logistic regression analyses. Those who reported being
“slow walkers” were the reference group, these results were reported as odds ratios (OR) and their
95% CI.
All analyses were incrementally adjusted according to different confounding factors. Model 0 was
unadjusted; Model 1 was adjusted for sociodemographic factors such as age, sex, educational level and
place of residence (urban/rural); Model 2 was additionally adjusted for BMI; finally Model 3 adjusted
additionally adjusted for lifestyles behaviours including smoking, alcohol, sleeping behaviour, sitting
time, and fruit and vegetable intake.
3. Results
Table 1 shows the characteristics of people by walking pace category. Approximately more than half
of the participants reported an average walking pace (55.5%), whereas only 22.2% reported a slow walking
pace. Compared to slow walkers, those who reported being average and brisk walkers were younger
(41.0 and 39.1 years, respectively). Slow walking pace was more commonly reported in women than in
men (60.8 versus 39.2%, respectively) and individuals with a lower education level. Individuals living in
urban settings reported a higher prevalence of brisk walking compared to those living in rural settings.
Slow walkers reported consuming more salt, less alcohol and more fruit and vegetables. They also had
a lower prevalence of being regular smokers. Total PA, transport-related PA, and moderate-intensity
physical activity were higher in brisk than slow walkers. However, vigorous-intensity PA was higher in
slow walkers than brisk walkers. Additionally, slow walkers had a higher prevalence of obesity compared
to brisk walkers (Table 1).
Table 1. Characterisation of the population by walking pace.
Variables Slow Pace Average Pace Brisk Pace
n (%) 1371 (22.2) 3429 (55.5) 1383 (22.4)
Sociodemographic
Age (years) * 55.7 (53.6; 57.8) 41.0 (40.0; 42.0) 39.1 (37.7; 40.5)
Sex, %
Women 60.8 (55.7; 65.7) 47.4 (44.2; 50.5) 51.1 (46.3; 55.9)
Men 39.2 (34.2; 44.2) 52.6 (49.4; 55.7) 48.9 (44.1; 53.7)
Place of residence, %
Urban 84.7 (81.6; 87.3) 88.7 (87.1; 90.2) 92.5 (90.5; 94.1)
Rural 15.3 (12.6; 18.3) 11.3 (9.8; 12.8) 7.5 (5.8; 9.5)
Educational Level, %
≤8 years 36.8 (32.4; 41.4) 13.0 (11.1; 15.0) 9.6 (7.3; 12.6)
9–12 years 48.0 (43.0; 53.1) 59.0 (55.8; 62.2) 55.2 (50.3; 59.9)
>12 years 15.2 (11.6; 19.6) 28.0 (50.3; 59.6) 35.2 (30.7; 40.1)
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Table 1. Cont.
Variables Slow Pace Average Pace Brisk Pace
Lifestyle
Smoking, %
Regular smoker 18.7 (14.9; 23.2) 26.3 (23.5; 29.4) 24.1 (20.2; 28.5)
Occasional smoker 6.4 (4.1; 9.7) 9.3 (7.5; 11.5) 7.8 (5.6; 10.7)
Ex-smoker 27.3 (23.4; 31.6) 24.7 (21.9; 27.6) 26.5 (22.4; 31.0)
Non-smoking 47.6 (42.5; 52.6) 39.7 (36.7; 42.7) 41.6 (37.0; 46.3)
Alcohol use, %
High consumption (AUDIT) 4.3 (1.8; 10.2) 5.0 (4.0; 7.3) 6.1 (3.7; 9.8)
F&V intake, %
Eats less than 5 F&V 87.7 (84.2; 90.5) 86.2 (83.6; 88.5) 81.5 (77.4; 85.0)
Salt intake (g/day) * 9.5 (9.2; 9.8) 9.1 (8.9; 9.2) 8.9 (8.6; 9.2)
Sleep hours, %
7–8 h 45.2 (40.4; 50.3) 54.2 (50.6; 57.3) 52.5 (47.8; 57.3)
≥9 h 25.9 (21.6; 30.6) 25.6 (23.0; 28.5) 23.4 (19.7; 27.6)
≤6 h 28.9 (24.4; 33.8) 20.2 (17.7; 23.0) 24.1 (20.2; 28.4)
Physical Activity
Total PA (MET/min/day) * 771.1 (633.1; 909.1) 1200.0 (1100.5; 1301.2) 1412.9 (1232.4; 1591.5)
Transport PA (min/day) * 46.6 (32.8; 60.4) 72.5 (64.2; 80.7) 78.5 (65.8; 91.1)
Sedentary Time (min/day) * 214.4 (196.9; 231.8) 198.8 (187.6; 210.1) 208.0 (190.3; 225.6)
Moderate PA (min/day) * 192.5 (162.7; 222.2) 231.0 (211.1; 250.9) 235.1 (202.9; 267.3)
Vigorous PA (min/day) * 261.9 (211.9; 311.8) 202.1 (181.2; 223.0) 220.8 (186.1; 255.5)
Physical Inactivity, % 38.8 (34.1; 43.6) 23.9 (21.3; 26.7) 18.9 (15.5; 22.8)
Adiposity
Body weight (kg) * 76.3 (74.6; 78.1) 75.7 (74.7; 76.7) 74.7 (73.3; 76.2)
BMI (kg/m2) * 30.2 (29.6; 30.9) 28.4 (28.1; 28.7) 27.7 (27.3; 28.1)
Nutritional status, %
Underweight 1.1 (0.0; 2.6) 1.5 (0.1; 2.6) 0.8 (0.0; 0.2)
Normal 21.8 (17.8; 26.4) 24.2 (21.6; 27.0) 27.0 (23.0; 31.4)
Overweight 29.9 (25.6; 34.6) 41.7 (38.6; 44.9) 42.4 (37.7; 47.3)
Obese 47.2 (42.1; 52.3) 32.6 (29.7; 35.6) 29.8 (25.6; 34.3)
Waist circumference (cm) * 98.3 (96.9; 99.8) 92.6 (91.7; 93.5) 91,3 (90.1; 92.4)
Central obesity, %
>102 cm men and >88 cm women 59.0 (53.9; 63.9) 41.3 (38.3; 44.4) 39.2 (34.6; 43.9)
Data presented by average walking pace (slow, average, brisk) and 95% CI for continuous variables (*) and in % and
95% CI for categorical variables. PA = Physical Activity; BMI = Body Mass Index; F&V = Fruits and Vegetable;
AUDIT = Alcohol Use Disorders Identification Test.
The associations of walking pace with fasting glucose and HbA1c are shown in Table 2. For the
unadjusted model average and brisk walkers had lower levels of fasting glucose (β: −7.74 and−11.05 mg/dL,
respectively) compare to slow walkers. Similar results were observed for HbA1c (β: −0.34 and −0.72% for
average and brisk walkers compare to slow walkers). However, after adjusting the model, for confounding
factors, only brisk walkers had lower levels of fasting glucose and HbA1c compared to slow walkers.
(Table 2). Besides, a lower glycaemia and HbA1c trend values for each rise in walking speed category were
observed (Figure 1).
The association between different walking pace and T2D is presented in Table 3. Compared to
slow walkers, those who reported being average or brisk walkers had a lower risk of T2D (OR: 0.32 and
0.22, respectively). When these analyses were adjusted for major confounding factors, the associations
were slightly attenuated but remained statistically significant (Table 3 and Figure 2).
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Table 2. Association of walking pace with fasting glucose and glycosylated haemoglobin A (HbA1c).
Variables Slow Pace
Average Pace Brisk Pace
β (95% CI) p-Value β (95% CI) p-Value
Fasting Glucose (mg/dL)
Model 0 1.00 (Ref.) −7.74 (−11.08; −4.40) <0.0001 −11.05 (−14.36; −7.75) <0.0001
Model 1 1.00 (Ref.) −2.55 (−5.67; 0.56) 0.109 −4.84 (−7.91; −1.79) 0.002
Model 2 1.00 (Ref.) −1.70 (−4.86; 1.34) 0.266 −3.64 (−6.72; −0.57) 0.020
Model 3 1.00 (Ref.) −1.31 (−4.43; 1.80) 0.410 −3.00 (−5.99; −0.11) 0.049
HbA1c (%)
Model 0 1.00 (Ref.) −0.34 (−0.57; −0.11) 0.004 −0.72 (−0.94; −0.49) <0.0001
Model 1 1.00 (Ref.) −0.08 (−0.30; 0.13) 0.464 −0.40 (−0.61; −0.17) <0.0001
Model 2 1.00 (Ref.) −0.08 (−0.29; −0.14) 0.493 −0.39 (−0.62; −0.16) 0.001
Model 3 1.00 (Ref.) −0.05 (−0.28; 0.18) 0.665 −0.37 (−0.60; −0.13) 0.002
Data presented as β-coefficient and its 95% CI by walking pace category estimated by linear regression analysis.
Slow walking pace was considered as a reference value (Ref). Statistical analyses were incrementally adjusted: Model
0—unadjusted; Model 1—adjusted by sociodemographic factors (age, sex, educational level and residence setting
(urban/rural); Model 2—was additionally adjusted for BMI; Model 3—was additionally adjusted for lifestyle factors
(smoking, alcohol, sleep duration, fruit and vegetable intake, and sitting time). HbA1c = Glycosylated Haemoglobin.
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Figure 1. Association of walking pace with fasting glucose and HbA1c. Data presented as adjusted
means and its 95% CI. Slow walking pace was considered as a reference value. Results were adjusted
for model 3—age, sex, educational level and residence setting (urban/rural), BMI, smoking, alcohol,
sleep duration, fruit and vegetable intake, and sitting time. The trends were stimated with regression
analyses and presented as β-coefficient and 95% CI for the outcome per one category change in walking
pace. HbA1c = Glycosylated Haemoglobin.
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Table 3. Association between walking pace and Type 2 Diabetes (T2D).
Variable Slow Pace
Average Pace Brisk Pace
OR (95% CI) p-Value OR (95% CI) p-Value
T2D
Model 0 1.00 (Ref.) 0.32 (0.4; 0.43) <0.0001 0.22 (0.15; 0.34) <0.0001
Model 1 1.00 (Ref.) 0.54 (0.38; 0.77) 0.001 0.42 (0.26; 0.66) <0.0001
Model 2 1.00 (Ref.) 0.58 (0.41; 0.83) 0.003 0.48 (0.31; 0.77) 0.002
Model 3 1.00 (Ref.) 0.59 (0.41; 0.84) 0.004 0.48 (0.30; 0.79) 0.004
Data presented as odds ratio (OR) and its 95% CI by walking pace category. Slow walking pace was considered as a
reference value (Ref.). The OR and its respective 95% CI were determined by logistic regression. Statistical analyses
were incrementally adjusted: Model 0—unadjusted; Model 1—adjusted by sociodemographic factors (age, sex,
educational level and residence setting (urban/rural); Model 2—was additionally adjusted for BMI; Model 3—was
additionally adjusted for lifestyle factors (smoking, alcohol, sleep duration, fruit and vegetable intake, and sitting
time). T2D = Type 2 Diabetes.
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4. Discussion
4.1. Walking Pace and Diabetes Biomarkers
Brisk walking pace was associated with lower blood glucose and HbA1c compared to those with
a slow walking pace. Both average and brisk walkers had a lower risk of T2D in comparison to slow
walkers. These associations were independent of age, sex, BMI, and other lifestyle behaviours.
4.2. What Was Already Known About This Subject?
Our findings are in agreement with international evidence, where average and brisk walking pace were
associated with lower glucose levels compared to slow walkers [25,26]. However, for HbA1c, the evidence
in the literature is discordant [25]. In this study, an association was observed between walking pace and
HbA1c, mainly for brisk walkers. However, other studies have not found an association between walking
pace and HbA1c, despite showing an association between walking pace and fasting glucose [27].
The associations found between walking pace and T2D agree with international existing
evidence [25–30]. However, other studies have shown that walking pace is also a strong predictor of
cardiovascular disease, cancer, and pre ature mortality in middle age [7–9,31] as well as cardiovascular
risk, cardiovascular events, and risk of death in older adults [32–34]. In ddition, walking pac has
be n used to estimate years of physical functioning lost in older adults and has been associated with
both low socioeconomic status and risk factors for non-communicable diseases (among th m T2D) [35].
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Concerning Latin American literature, risk factors associated with T2D [36] and walking pace [37,38]
have been studied as a functional marker in the population. However, the association between walking
pace and health outcomes has been poorly studied [16,17]. In this context, our findings are consistent
with a study carried out in Peru, in which a slow walking pace was associated with a higher prevalence
of T2D. Nevertheless, the Peruvian study was conducted in an older population and, therefore, a fair
comparison cannot be performed [16].
4.3. How Does This Study Contribute to Science?
If causal, the early assessment of walking pace could help as a cardiovascular and metabolic
risk assessment in older adults [34]. More specifically, as a tool to identify individuals who have a
high diabetic risk. Therefore, walking pace could be used as a screening question in primary care
settings to identify a high-risk individual who would benefit from further metabolic screening but
also physical activity intervention. Moreover, walking pace has been suggested as an easy-to-apply
and low-cost screening tool, with important prediction ability for cardiovascular diseases, cancer,
and premature mortality [39]. Besides, walking pace could be a simple, safe, free, cheap and feasible
way to increase physical activity and maximise its health benefits in T2D population. Even more, if we
consider that physical inactivity and higher levels of sitting time are two of the main modifiable risk
factors associated with T2D [36] and that people with T2D have higher sedentary physical activity
patterns and lower levels of physical activity than people without T2D [20].
4.4. Strengths and Limitations
This is the first study in Chile that determines the relationship between walking pace, diabetes
biomarkers, and prevalence of T2D. In addition, fasting glucose and HbA1c have been measured using a
standardised protocol, and prevalence of diabetes has been derived using WHO criteria. We were also able
to adjust our analyses for a comprehensive list of confounding factors (BMI, sociodemographic factors,
and lifestyle factors). However, we cannot remove the effect of confounding due to waist circumference
and physical activity, as this might have resulted in multicollinearity issues. Other potential confounders,
such as functional capacity, muscle strength, and balance, were unfortunately not collected in the CNHS.
Finally, we cannot eliminate the potential effect of multimorbidity on our findings: people who reported
a slow walking pace may also have other chronic diseases that may limit their walking pace. Although
the walking pace was self-reported, previous studies have shown that this simple question is a significant
predictor of health [32]. Another aspect to consider is that due to the cross-sectional nature of our
study, our results cannot prove causality. However, previous evidence from randomised controlled trials
suggests that walking is associated with better glycaemic control in healthy and diabetic patients [40–42].
5. Conclusions
Brisk walking pace was associated with a lower concentration of blood glucose and HbA1c
compared to those with slow walking pace in the Chilean population. Besides, an average or brisk
walking pace was associated with a lower likelihood of T2D compared to slow walkers.
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